BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24039441)

  • 1. Lack of effect of methotrexate in budesonide-refractory collagenous colitis.
    Münch A; Bohr J; Vigren L; Tysk C; Ström M
    Clin Exp Gastroenterol; 2013; 6():149-52. PubMed ID: 24039441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-centre experience with anti-tumour necrosis factor treatment in budesonide-refractory microscopic colitis patients.
    Daferera N; Hjortswang H; Ignatova S; Münch A
    United European Gastroenterol J; 2019 Nov; 7(9):1234-1240. PubMed ID: 31700636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab in budesonide and methotrexate refractory collagenous colitis.
    Münch A; Ignatova S; Ström M
    Scand J Gastroenterol; 2012 Jan; 47(1):59-63. PubMed ID: 22149977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
    Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
    Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic Therapy for Budesonide-refractory, -dependent or -intolerant Microscopic Colitis: a Multicentre Cohort Study from the GETAID.
    Boivineau G; Zallot C; Zerbib F; Plastaras L; Amiot A; Boivineau L; Koch S; Peyrin-Biroulet L; Vuitton L
    J Crohns Colitis; 2022 Dec; 16(12):1816-1824. PubMed ID: 35793161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
    Miehlke S; Madisch A; Kupcinskas L; Petrauskas D; Böhm G; Marks HJ; Neumeyer M; Nathan T; Fernández-Bañares F; Greinwald R; Mohrbacher R; Vieth M; Bonderup OK;
    Gastroenterology; 2014 May; 146(5):1222-30.e1-2. PubMed ID: 24440672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining clinical criteria for clinical remission and disease activity in collagenous colitis.
    Hjortswang H; Tysk C; Bohr J; Benoni C; Kilander A; Larsson L; Vigren L; Ström M
    Inflamm Bowel Dis; 2009 Dec; 15(12):1875-81. PubMed ID: 19504614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide for the treatment of collagenous colitis: first results of a pilot trial.
    Tromm A; Griga T; Möllmann HW; May B; Müller KM; Fisseler-Eckhoff A
    Am J Gastroenterol; 1999 Jul; 94(7):1871-5. PubMed ID: 10406251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial.
    Bonderup OK; Hansen JB; Teglbjaerg PS; Christensen LA; Fallingborg JF
    Gut; 2009 Jan; 58(1):68-72. PubMed ID: 18669576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral budesonide therapy improves quality of life in patients with collagenous colitis.
    Madisch A; Heymer P; Voss C; Wigginghaus B; Bästlein E; Bayerdörffer E; Meier E; Schimming W; Bethke B; Stolte M; Miehlke S
    Int J Colorectal Dis; 2005 Jul; 20(4):312-6. PubMed ID: 15549326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of prolonged release budesonide granules in mesalazine-refractory ulcerative colitis: A multi-centre Phase IIa study (TOPICAL-1).
    Fellermann K; Schiefke I; Rácz I; Derova J; Jonaitis L; Wehrum S; Nacak T; Greinwald R
    United European Gastroenterol J; 2020 Dec; 8(10):1186-1195. PubMed ID: 33028169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis.
    Bonderup OK; Hansen JB; Birket-Smith L; Vestergaard V; Teglbjaerg PS; Fallingborg J
    Gut; 2003 Feb; 52(2):248-51. PubMed ID: 12524408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial.
    Miehlke S; Heymer P; Bethke B; Bästlein E; Meier E; Bartram HP; Wilhelms G; Lehn N; Dorta G; DeLarive J; Tromm A; Bayerdörffer E; Stolte M
    Gastroenterology; 2002 Oct; 123(4):978-84. PubMed ID: 12360457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.
    Münch A; Bohr J; Miehlke S; Benoni C; Olesen M; Öst Å; Strandberg L; Hellström PM; Hertervig E; Armerding P; Stehlik J; Lindberg G; Björk J; Lapidus A; Löfberg R; Bonderup O; Avnström S; Rössle M; Dilger K; Mueller R; Greinwald R; Tysk C; Ström M;
    Gut; 2016 Jan; 65(1):47-56. PubMed ID: 25425655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of prednisone-refractory collagenous colitis with budesonide.
    Lanyi B; Dries V; Dienes HP; Kruis W
    Int J Colorectal Dis; 1999 Feb; 14(1):58-61. PubMed ID: 10207732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for treating collagenous colitis.
    Chande N; McDonald JW; MacDonald JK
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003575. PubMed ID: 17054177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vedolizumab in Refractory Microscopic Colitis: An International Case Series.
    Rivière P; Münch A; Michetti P; Chande N; de Hertogh G; Schoeters P; Ferrante M; Vermeire S; Van Assche G
    J Crohns Colitis; 2019 Mar; 13(3):337-340. PubMed ID: 30329034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
    Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
    Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide.
    Miehlke S; Madisch A; Voss C; Morgner A; Heymer P; Kuhlisch E; Bethke B; Stolte M
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1115-9. PubMed ID: 16305725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beclomethasone dipropionate in microscopic colitis: Results of an exploratory open-label multicentre study (COLCO).
    Corte T; Janssens E; D'Hondt A; Thorrez K; Arts J; Dejaegher K; D'Heygere F; Holvoet A; van Besien B; Harlet L; Peeters H; Moerkercke WV; Baert F
    United European Gastroenterol J; 2019 Nov; 7(9):1183-1188. PubMed ID: 31700631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.